SCHEMBL5065652

SCHEMBL5065652

CC(=O)N(C)c1ccc(OCc2cc3ccc(F)cc3n2C(=O)O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.43
POLB P06746 1/20 0.43
RXRA P19793 2/20 0.40
NR1H2 P55055 2/20 0.40
NR1H3 Q13133 2/20 0.40
LMNA P02545 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
HTR1A P08908 1/20 0.39
DRD2 P14416 1/20 0.39
HTR2A P28223 1/20 0.39
HTT P42858 2/20 0.38
HSP90AA1 P07900 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MAOB P27338 4/20 0.37
PDE10A Q9Y233 2/20 0.36
PPARA Q07869 1/20 0.36
CNR2 P34972 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16835376 0.77 ALDH1A1 (0.37) ALDH1A1MAOBKDM4E
SCHEMBL5058079 0.72 MLNR (0.38) MAPTHTR1ADRD2HTR2A
SCHEMBL5062416 0.71 HTR2A (0.33) SMN1; SMN2POLBLMNAHTR1ADRD2
SCHEMBL5067217 0.71 CCR2 (0.39) LMNAALDH1A1HTR2AKDM4E
SCHEMBL5065659 0.68 NR1H2 (0.48) RXRANR1H2NR1H3PPARA
SCHEMBL6393684 0.65 SMN1; SMN2 (0.56) SMN1; SMN2POLBLMNAALDH1A1MAPT
SCHEMBL3832407 0.65 ALDH1A1 (0.77) SMN1; SMN2POLBLMNAALDH1A1MAPT
SCHEMBL25184142 0.62 MTNR1A (0.49) SMN1; SMN2ALDH1A1KDM4E
SCHEMBL16835407 0.62 OXER1 (0.42) SMN1; SMN2LMNAALDH1A1KDM4E
SCHEMBL6783648 0.62 POLB (0.64) SMN1; SMN2POLBLMNAALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255111-A1 Tissue Factor Production Inhibitor SANKYO COMPANY LIMITED (JP) 2008-10-16 US claimed
EP-1764075-A1 TISSUE FACTOR PRODUCTION INHIBITOR Sankyo Company, Limited (JP) 2007-03-21 EP claimed
US-20080255111-A1 Tissue Factor Production Inhibitor SANKYO COMPANY LIMITED (JP) 2008-10-16 US disclosed
EP-1764075-A1 TISSUE FACTOR PRODUCTION INHIBITOR Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255111-A1 Tissue Factor Production Inhibitor PTAFR, PLAT, TFPI SMN1; SMN2 3428/4885POLB 2926/4885RXRA 84/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.